| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6576665 | FRESENIUS MEDCL | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
Apr, 2021
(3 years ago) | |
| US6875445 | FRESENIUS MEDCL | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
Jul, 2021
(2 years ago) | |
Phoslo Gelcaps is owned by Fresenius Medcl.
Phoslo Gelcaps contains Calcium Acetate.
Phoslo Gelcaps has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Phoslo Gelcaps are:
- US6576665
- US6875445
Phoslo Gelcaps was authorised for market use on 02 April, 2001.
Phoslo Gelcaps is available in capsule;oral dosage forms.
The generics of Phoslo Gelcaps are possible to be released after 30 July, 2021.
Drugs and Companies using CALCIUM ACETATE ingredient
Market Authorisation Date: 02 April, 2001
Treatment: NA
Dosage: CAPSULE;ORAL
How can I launch a generic of PHOSLO GELCAPS before it's drug patent expiration?
More Information on Dosage
PHOSLO GELCAPS family patents
